PRIMARY CARE SEQUENTIAL USE OF FIB-4 AND THE ENHANCED LIVER FIBROSIS TEST TO STRATIFY PATIENTS WITH NONALCOHOLIC FATTY LIVER ACIDE DOUBLES CIRRHOSIS DETECTION AND REDUCES REFERRALS OF PATIENTS WITH MILD DISEASE

被引：0
|
作者：
Srivastava, A. [1 ,2 ]
Gailer, R. [3 ]
Demma, S. [1 ,2 ]
Warner, A. [3 ]
Suri, D. [4 ]
Morgan, S.
Tanwar, S. [1 ]
Sennett, K. [5 ]
Thorburn, D. [1 ,2 ]
Parkes, J. [1 ,6 ]
Tsochatzis, E. [1 ,2 ]
Rosenberg, W. [1 ,2 ]
机构：
[1] UCL, Inst Liver & Digest Hlth, London, England
[2] Royal Free London NHS Fdn Trust, Hepatol & Liver Transplantat, London, England
[3] UCL, Primary Care & Populat Hlth, London, England
[4] Whittington Hosp, Dept Hepatol, London, England
[5] Islington Clin Commissioning Grp, Primary Care, London, England
[6] Univ Southampton, Publ Hlth Sci & Med Stat, Southampton, Hants, England
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)00802-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-280
引用
收藏
页码：S474 / S475
页数：2
相关论文
共 50 条
  • [31] Health economics of the enhanced liver fibrosis test in the detection of advanced liver fibrosis in patients with non-alcoholic fatty liver disease in the UK
    Younossi, Zobair
    Stepanova, Maria
    Paik, James
    Nader, Fatema
    Henry, Linda
    Pollock, Richard
    JOURNAL OF HEPATOLOGY, 2023, 78 : S857 - S858
  • [32] Screening for hepatic fibrosis in primary care by FIB-4 score, followed in second line f the ELF (enhanced liver fibrosis) test: what are the best thresholds?
    Ouzan, Denis
    Peneranda, Guillaume
    Jlaiel, Malik
    Corneille, Jeremie
    JOURNAL OF HEPATOLOGY, 2023, 78 : S834 - S834
  • [33] Fibrosis-4 Score (FIB-4) Provides Consistent Assessment of Healthcare Costs and Healthcare Resource Utilization (HCRU) Among Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) Patients with Advanced Fibrosis
    Gordon, Stuart C.
    Ozbay, Burak
    Parker, Emily
    Korrer, Stephanie
    Wong, Robert J.
    HEPATOLOGY, 2018, 68 : 617A - 618A
  • [34] IMPROVEMENT IN PRIMARY CARE PHYSICIAN (PCP) KNOWLEDGE ABOUT NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AFTER IMPLEMENTING A FIB-4 BASED REFERRAL STRATEGY
    Chu, Janet N.
    Fox, Rena K.
    Brandman, Danielle
    Falliers, Delia
    Islam, Kendall
    Goldman, Max L.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 : S119 - S120
  • [35] ASSESSMENT OF HEPATIC FIBROSIS SCREENING IN PRIMARY CARE USING AUTOMATIC CALCULATION OF THE FIB-4 SCORE, FOLLOWED IN SECOND LINE BY AN ELF ( ENHANCED LIVER FIBROSIS) TEST
    Ouzan, Denis
    Penaranda, Guillaume
    Jlaiel, Malik
    Corneille, Jeremie
    HEPATOLOGY, 2023, 78 : S765 - S766
  • [36] SMART PHRASE IMPROVES FIBROSIS ASSESSMENT IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE IN A RESIDENT PRIMARY CARE CLINIC
    White, Megan E.
    Crippin, Jeffrey S.
    Mchenry, Scott A.
    GASTROENTEROLOGY, 2021, 160 (06) : S837 - S837
  • [37] Enhanced Liver Fibrosis (ELF) Test Can Accurately Predict Advanced Fibrosis in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease (NAFLD)
    Younossi, Zobair
    Felix, Sean
    Jeffers, Thomas
    Younossi, Elena
    Nader, Fatema
    Pham, Huong
    Afendy, Arian
    Cable, Rebecca
    Racila, Andrei
    Younoszai, Zahra
    Lam, Brian P.
    Golabi, Pegah
    Henry, Linda
    Clement, Stephen
    Stepanova, Maria
    DIABETES, 2020, 69
  • [38] Early screening for chronic liver disease: impact of a FIB-4 first integrated care pathway to identify patients with significant fibrosis
    Mignot, V.
    Chirica, C.
    Tron, L.
    Borowik, A.
    Borel, A. L.
    Rostaing, L.
    Bouillet, L.
    Decaens, T.
    Guergour, D.
    Costentin, C. E.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [39] Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients With Advanced Fibrosis
    Chan, Wah-Kheong
    Treeprasertsuk, Sombat
    Goh, George Boon-Bee
    Fan, Jian-Gao
    Song, Myeong Jun
    Charatcharoenwitthaya, Phunchai
    Duseja, Ajay
    Dan, Yock-Young
    Imajo, Kento
    Nakajima, Atsushi
    Ho, Khek-Yu
    Goh, Khean-Lee
    Wong, Vincent Wai-Sun
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (12) : 2570 - +
  • [40] Reply to: "FIB-4 cut off of 1.3 may be inappropriate in a primary care referral pathway for patients with non-alcoholic fatty liver disease"
    Tsochatzis, Emmanuel A.
    Srivastava, Ankur
    Rosenberg, William
    JOURNAL OF HEPATOLOGY, 2020, 73 (01) : 217 - 218
12345